Answers are grounded in this paper and cite their sources.
FDA Oncology Center's @Falleh_Fallah and colleagues discuss loss of equipoise and other trial conduct challenges in an era of breakthrough therapies - via @JCO_ASCO.
No takes yet. Share an insight, caveat, or question.
Fallah et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: